Financial Toxicity More Likely in Younger, Nonwhite Women Cancer Survivors

Share this content:
Survivors of cancer tend to experience more material and psychological financial hardship when compared with those who have not received a cancer diagnosis.
Survivors of cancer tend to experience more material and psychological financial hardship when compared with those who have not received a cancer diagnosis.

Survivors of cancer tend to experience more material and psychological financial hardship when compared with those who have not received a cancer diagnosis, according to a recent study.1

Investigators sought to estimate the prevalence of financial hardship linked to a cancer diagnosis in the United States as well as common characteristics found in those who experience it.

A total of 1202 adult cancer survivors were identified from the 2011 Medical Expenditure Panel Survey Experiences With Cancer questionnaire. The following criteria were used to identify hardship: borrowing money or going into debt, filing for bankruptcy, the inability to pay one's share of medical costs, or making other financial sacrifices due to a cancer diagnosis, treatment, and lasting effects. 

Material financial hardship as well as psychological financial hardship occurred more commonly in survivors 65 years and younger (28.4% vs 13.8%; P < .001; 31.9% vs 14.7%; P < .001, respectively).

RELATED: Financial Toxicity Among Topics Presented at AACR Conference

According to adjusted analyses, nonwhite women cancer survivors aged 18 to 64 years, who had been treated more recently and had to change or quit their jobs due to their diagnosis were significantly more likely to report hardship.  Younger age was correlated with both more financial and psychological hardship, as was being uninsured, and having more recent treatment.

Reference

  1. Yabroff KR, Dowling EC, Guy GP Jr, et al. Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors [published online ahead of print December 7, 2015]. J Clin Oncol. doi: 10.1200/JCO.2015.62.0468.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters